Financials SBI Life Insurance Company Limited Bombay S.E.

Equities

SBILIFE

INE123W01016

Life & Health Insurance

Market Closed - Bombay S.E. 04:59:11 02/07/2024 BST 5-day change 1st Jan Change
1,490 INR -0.83% Intraday chart for SBI Life Insurance Company Limited +2.18% +4.38%

Valuation

Fiscal Period: March 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 583,400 641,017 880,912 1,121,866 1,102,085 1,504,218 - -
Enterprise Value (EV) 1 559,194 626,785 853,807 1,089,823 1,060,436 1,454,990 1,452,086 1,446,335
P/E ratio 44 x 45.1 x 60.5 x 74.6 x 64.1 x 79.4 x 69 x 60.1 x
Yield 0.34% - 0.28% 0.18% 0.23% 0.18% 0.22% 0.24%
Capitalization / Revenue 1.32 x 1.46 x 1.07 x 1.35 x 1.35 x 1.13 x 1.2 x 1.04 x
EV / Revenue 1.26 x 1.43 x 1.04 x 1.31 x 1.3 x 1.1 x 1.16 x 1 x
EV / EBITDA - - - - - - - -
EV / FCF - -10,046,830 x - - - - - -
FCF Yield - -0% - - - - - -
Price to Book 7.7 x 7.33 x 8.47 x 9.65 x 8.47 x 10.1 x 9.02 x 7.93 x
Nbr of stocks (in thousands) 1,000,000 1,000,026 1,000,071 1,000,371 1,000,895 1,001,577 - -
Reference price 2 583.4 641.0 880.8 1,121 1,101 1,502 1,502 1,502
Announcement Date 25/04/19 05/05/20 03/05/21 28/04/22 26/04/23 26/04/24 - -
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 442,612 438,428 820,849 830,272 815,985 1,326,314 1,249,060 1,451,541
EBITDA - - - - - - - -
EBIT 1 13,740 14,142 15,424 15,913 17,594 19,446 21,857 25,350
Operating Margin 3.1% 3.23% 1.88% 1.92% 2.16% 1.47% 1.75% 1.75%
Earnings before Tax (EBT) 1 13,729 14,135 15,425 15,608 17,584 19,421 22,355 25,970
Net income 1 13,268 14,222 14,558 15,060 17,206 18,938 21,757 24,826
Net margin 3% 3.24% 1.77% 1.81% 2.11% 1.43% 1.74% 1.71%
EPS 2 13.27 14.22 14.55 15.04 17.18 18.90 21.78 24.98
Free Cash Flow - -62,386 - - - - - -
FCF margin - -14.23% - - - - - -
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share 2 2.000 - 2.500 2.000 2.500 2.700 3.250 3.671
Announcement Date 25/04/19 05/05/20 03/05/21 28/04/22 26/04/23 26/04/24 - -
1INR in Million2INR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 S1 2024 Q3 2024 Q4 2025 Q1
Net sales - 208,967 - - - - - 275,253 266,267 - - - - - - -
EBITDA 1 - - - - 4,252 - - 4,515 - - 6,320 5,759 - 6,402 - -
EBIT 1 2,332 6,218 2,340 2,811 3,822 6,940 2,676 3,875 3,112 7,930 3,897 10,597 - 10,504 11,818 5,949
Operating Margin - 2.98% - - - - - 1.41% 1.17% - - - - - - -
Earnings before Tax (EBT) 1 - - 2,334 - 3,814 6,941 2,674 3,866 - - 3,897 4,204 - 3,866 - -
Net income 1 2,328 5,324 2,232 2,466 3,641 6,722 2,628 3,767 3,041 7,768 3,810 4,170 7,612 3,831 7,977 -
Net margin - 2.55% - - - - - 1.37% 1.14% - - - - - - -
EPS 2 2.330 5.320 2.230 2.460 3.640 6.710 2.630 3.760 3.040 7.760 3.800 4.400 - 3.700 7.799 -
Dividend per Share 2 - 2.500 - - - 2.000 - - - 2.500 - - - - 3.500 -
Announcement Date 22/01/21 03/05/21 26/07/21 27/10/21 21/01/22 28/04/22 28/07/22 21/10/22 21/01/23 26/04/23 25/07/23 - 27/10/23 - - -
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 24,206 14,232 27,105 32,042 41,649 47,459 52,132 57,883
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow - -62,386 - - - - - -
ROE (net income / shareholders' equity) 18.8% 17.4% 15.2% 13.7% 14% 13.8% 15.7% 15.7%
ROA (Net income/ Total Assets) 1.02% 0.93% 0.76% 0.61% 0.59% 0.63% 0.59% 0.57%
Assets 1 1,305,906 1,527,737 1,915,592 2,453,951 2,940,140 3,089,587 3,681,361 4,353,505
Book Value Per Share 2 75.80 87.40 104.0 116.0 130.0 149.0 167.0 189.0
Cash Flow per Share - - 236.0 218.0 - - - -
Capex - - - - - - - -
Capex / Sales - - - - - - - -
Announcement Date 25/04/19 05/05/20 03/05/21 28/04/22 26/04/23 26/04/24 - -
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
  1. Stock Market
  2. Equities
  3. SBILIFE Stock
  4. SBILIFE Stock
  5. Financials SBI Life Insurance Company Limited